Research Article| Volume 99, ISSUE 10, P1249-1256, October 1999

Download started.



Food or Drug?
    D. L. Taren (corresponding author) is an associate professor and K. Bruinsma is a research assistant with the Arizona Prevention Center, University of Arizona, College of Medicine, 1612 E Mabel St, Tucson, AZ 85719, USA
    Search for articles by this author
    D. L. Taren (corresponding author) is an associate professor and K. Bruinsma is a research assistant with the Arizona Prevention Center, University of Arizona, College of Medicine, 1612 E Mabel St, Tucson, AZ 85719, USA
    Search for articles by this author


      Although addictive behavior is generally associated with drug and alcohol abuse or compulsive sexual activity, chocolate may evoke similar psychopharmacologic and behavioral reactions in susceptible persons. A review of the literature on chocolate cravings indicates that the hedonic appeal of chocolate (fat, sugar, texture, and aroma) is likely to be a predominant factor in such cravings. Other characteristics of chocolate, however, may be equally as important contributors to the phenomena of chocolate cravings. Chocolate may be used by some as a form of self-medication for dietary deficiencies (eg, magnesium) or to balance low levels of neurotransmitters involved in the regulation of mood, food intake, and compulsive behaviors (eg, serotonin and dopamine). Chocolate cravings are often episodic and fluctuate with hormonal changes just before and during the menses, which suggests a hormonal link and confirms the assumed gender-specific nature of chocolate cravings. Chocolate contains several biologically active constituents (methylxanthines, biogenic amines, and cannabinoid-like fatty acids), all of which potentially cause abnormal behaviors and psychological sensations that parallel those of other addictive substances. Most likely, a combination of chocolate's sensory characteristics, nutrient composition, and psychoactive ingredients, compounded with monthly hormonal fluctuations and mood swings among women, will ultimately form the model of chocolate cravings. Dietetics professionals must be aware that chocolate cravings are real. The psychopharmacologic and chemosensory effects of chocolate must be considered when formulating recommendations for overall healthful eating and for treatment of nutritionally related health issues. J Am Diet Assoc. 1999;99: 1249–1256.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Academy of Nutrition and Dietetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rudin R.A
        The Craving Brain. Harper Collins, New York, NY1997
        • Weingarten H.P.
        • Elston D.
        The phenomenology of food cravings.
        Appetite. 1991; 15: 231-246
        • Hill A.J.
        • Heaton-Brown L.
        The experience of food craving.
        J Psychosom Res. 1994; 38: 801-814
        • Rozin P.
        • Levine E.
        • Stoess C.
        Chocolate craving and liking.
        Appetite. 1991; 17: 199-212
        • Weingarten H.P.
        • Elston D.
        Food cravings in a college population.
        Appetite. 1991; 17: 167-175
        • Wood G.A.R.
        • Lass R.A.
        Cocoa. 4th ed. Longman, New York, NY1985 (;28–35,596.)
        • Roberts A.J.
        • Koob G.F.
        The neurobiology of addiction.
        Alcohol Health Res World. 1997; 21: 101-106
        • Hetherington M.M.
        • Macdiarmid J.I.
        “Chocolate addiction”.
        Appetite. 1993; 21: 233-246
        • Rodin J.
        • Mancuso J.
        • Granger J.
        • Nelbach E.
        Food cravings in relation to body mass index, restraint and estradiol levels.
        Appetite. 1991; 17: 177-185
        • Schuman M.
        • Gitlin M.J.
        • Fairbanks L.
        Sweets, chocolate, and atypical depressive traits.
        J Nerv Ment Dis. 1987; 175: 491-495
        • Michener W.
        • Rozin P.
        Pharmacological versus sensory factors in the satiation of chocolate craving.
        Physiol Behav. 1994; 56: 419-422
        • Drewnowski A.
        Energy intake and sensory properties of food.
        Am J Clin Nutr. 1995; 62: 1081S-1085S
        • Desor J.A.
        • Mailer O.
        • Greene L.S.
        Preference for sweet in humans.
        in: Weiffenbacch J. Taste and Development The Genesis of Sweet Preference. US Dept of Health, Education, and Welfare, Washington, DC1997 (Publication No. NIH 77–1068.)
        • Colombo G.
        • Agabio R.
        • Diaz G.
        • Fa M.
        • Lobina C.
        • Reali R.
        • Gessa G.L.
        Sardinian alcohol-preferring rats prefer chocolate and sucrose over ethanol.
        Alcohol. 1997; 14: 611-615
        • Falk J.
        Sweetabuse, the addiction model.
        in: Weiffenbacch J. Taste and Development The Genesis of Sweet Preference. US Dept of Health Education and Welfare, Washington DC1997 (Publication No. NIH 77–1068.)
        • Hurst W.J.
        • Marin R.A.
        • Zoumas B.L.
        Biogenic amines in chocolate—a review.
        Nutr Rep Int. 1982; 26: 1081-1086
        • Sabelli H.C.
        • Javaid J.I.
        Phenylethylamine modulation of affect.
        J Neuropsychol. 1995; 7: 6-14
        • Paterson I.A.
        • Juorio A.V.
        • Boulton A.A.
        J Neurochem. 1990; 55: 1827-1837
        • Philips S.R.
        • Robson A.M.
        In vivo release of endogenous dopamine from the rat caudate nucleus by phenylethylamine.
        Neuropharmacology. 1983; 22: 1297-1301
        • Shannon H.E.
        • Cone E.J.
        • Yousefnejad D.
        Physiologic effects and plasma kinetics of β-phenyl-ethylamine and its N-methyl homolog in the dog.
        J Pharmacol Exp Ther. 1982; 223: 190-196
        • Marley B.
        • Blackwell B.
        Interactions of monoamine oxidase inhibitors, amines and foodstuffs.
        Adv Pharmacol Chemother. 1970; 8: 185-239
        • Schifano F.
        • Magni G.
        MDMA (“ecstasy”) abuse.
        Biol Psychiatry. 1994; 36: 763-767
        • McKim W.A
        Drugs and Behavior. Prentice Hall, NJ1997
        • Nehlig A.
        • Daval J.L.
        • Debry G.
        Caffeine and the central nervous system.
        Brain Res Rev. 1992; 17: 139-170
        • Tarka S.M.
        The toxicology of cocoa and methylxanthines.
        Crit Rev Toxicol. 1982; 9: 275-312
        • Mumford G.K.
        • Evans S.M.
        • Kaminski B.J.
        • Preston K.L.
        • Sannerud C.A.
        • Silverman K.
        • Griffiths R.R.
        Discriminative stimulus and subjective effects of theobromine and caffeine in humans.
        Psychopharmacology (Berl). 1994; 115: 1-8
        • Barone J.J.
        • Roberts H.R.
        Caffeine consumption.
        Food Chem Toxicol. 1996; 34: 119-129
        • di Tomaso E.
        • Beltramo M.
        • Piomelli D.
        Brain cannabinoids in chocolate.
        Nature. 1996; 382: 677-678
        • Devane W.A.
        • Lumir H.
        • Aviva B.
        • Pertwee R.G.
        • Stevenson L.A.
        • Griffin G.
        • Gibson D.
        • Mandelbaum A.
        • Etinger A.
        • Mechoulam R.
        Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
        Science. 1992; 258: 1946-1949
        • Restak R.
        Brain by design.
        The Sciences. September-October 1993; : 27-33
        • Di Marzo V.
        • Fontana A.
        • Cadas H.
        • Schinelli S.
        • Cimino G.
        • Schwartz J.C.
        • Piomelli D.
        Formation and inactivation of endogenous cannabinoid anandamide in central neurons.
        Nature. 1994; 372: 686-691
        • Pertwee R.G.
        In vivo interactions between psychotropic cannabinoids and other drugs involving central and peripheral neurochemical mediators.
        in: Murphy L. Bartke A. Marijuana/Cannabinoids Neurobiology and Neurophysiology. CRC Press, Boca Raton, Fla1992: 165-218
        • Abraham G.E.
        • Lubran M.M.
        Serum and red cell magnesium levels in patients with premenstrual tension.
        Am J Clin Nutr. 1981; 34: 2364-2366
        • Abraham G.E.
        The normal menstrual cycle.
        in: Givens J.R. Endocrine Causes of Menstrual Disorders. Year Book Medical Publishers, Chicago, Ill1978: 15-44
        • Rude R.K.
        • Behune J.E.
        Renal tubular maximum for magnesium in normal, hyperparathyroid, and hypo parathyroid man.
        J Clin Endocrinol Metab. 1980; 51: 1425-1431
        • Abraham G.E.
        Premenstrual tension.
        in: Levanthal M. Current Problems in Obstetrics and Gynecology. Year Book Medical Publishers, Chicago, Ill1980: 1-48
        • Hill A.J.
        • Weaver C.F.L.
        Food craving, dietary restraint and mood.
        Appetite. 1991; 17: 187-197
        • Wurtman R.J.
        • Wurtman J.J.
        Do carbohydrates affect food intake via neurotransmitter activity?.
        Appetite. 1988; 11: 42-47
        • Wurtman R.J.
        • Wurtman J.J.
        Carbohydrate craving, obesity and brain serotonin.
        Appetite. 1986; 7: 99-103
        • Curzon G.
        Serotonin and appetite.
        Ann N Y Acad Sci. 1990; 600: 521-529
        • Fernstrom J.D.
        Dietary amino acids and brain function.
        J Am Diet Assoc. 1994; 94: 71-77
        • Wurtman J.J.
        Neurotransmitter control of carbohydrate consumption.
        Ann N Y Acad Sci. 1985; 443: 145-151
        • Macdiarmid J.I.
        • Hetherington M.M.
        Mood modulation by food.
        Br J Clin Psychol. 1995; 34: 129-138
        • Bancroft J.
        • Beckstrum T
        Premenstrual syndrome.
        Clin Endocrinol. 1985; 22: 313-336
        • Bancroft J.
        • Cook A.
        • Williamson L.
        Food craving, mood and the menstrual cycle.
        Psychol Med. 1988; 18: 855-860
        • Abraham G.E.
        Nutritional factors in the etiology of the premenstrual tension syndromes.
        J Reprod Med. 1993; 28: 446-464
        • Cohen T.
        • Sherwin B.B.
        • Fleming A.S.
        Food cravings, mood and the menstrual cycle.
        Horm Behav. 1987; 21: 457-470
        • Dye I.
        • Blundell J.E.
        Menstrual cycle and appetite control.
        Hum Reprod. 1997; 12: 1142-1151
        • Bancroft J.
        • Rennie D.
        The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms.
        J Psychosom Res. 1993; 37: 195-202
        • Bowen D.J.
        • Grunberg N.E.
        Variations in food preference and consumption across the menstrual cycle.
        Physiol Behav. 1990; 47: 287-291
        • Tomerelli R.
        • Grunewald K.K.
        Menstrual cycle and food cravings in young college women.
        J Am Diet Assoc. 1987; 87: 311-316
        • Buffensteine R.
        • Poppitt S.D.
        • McDevitt R.M.
        • Prentice A.M.
        Food intake and the menstrual cycle.
        Physiol Behav. 1995; 58: 1067-1077
        • Blundell J.E.
        Serotonin and the biology of feeding.
        Am J Clin Nutr. 1992; 55: 155S-159S
        • Leibowitz S.F.
        Brain peptides and obesity.
        Obes Res. 1995; 3: 573S-589S
        • Tempel D.L.
        • Leibowitz S.F.
        Adrenal steroid receptors.
        J Neuroendocrinol. 1994; 6: 479-501
        • Stanley B.G.
        • Daniel D.R.
        • Chin A.S.
        • Leibowitz S.F.
        Paraventricular nucleus injections of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion.
        Peptides. 1985; 6: 1205-1211
        • Chae H.J.
        • Hoebel B.G.
        • Tempel D.L.
        • Paredes M.
        • Leibowitz S.F.
        Neuropeptide Y, galanin and opiate agonists have differential effects on nutrient ingestion [abstract].
        Soc Neurosci Abstracts. 1995; 21: 696
        • Tempel D.L.
        • Leibowitz K.J.
        • Leibowitz S.F.
        Effects of PVN galanin on macronutrient selection.
        Peptides. 1988; 9: 309-314
        • Leibowitz S.F.
        • Akabayashi A.
        • Alexander J.T.
        • Wang J.
        Gonadal steroids and hypothalamic galanin and neuropeptide Y.
        Endocrinology. 1998; 139: 1771-1780
        • Drewnowski A.
        Fats and food acceptance.
        in: Gaull F.E. Kosonis F.N. Mackey M.A. Nutrition in the 90's. Marcel Dekker, New York, NY1991: 25-39
        • Drewnowski A.
        • Krahn D.D.
        • Demitrack M.A.
        • Nairn K.
        • Gosnell B.A.
        Taste responses and preferences for sweet high-fat foods.
        Physiol Behav. 1992; 51: 371-379
        • Dum J.
        • Gransch C.H.
        • Herz A.
        Activation of hypothalamic β-endorphin pools by reward induced by highly palatable food.
        Pharmacol Biochem Behav. 1983; 33: 119-126
        • Yeomans M.R.
        • Gray R.W.
        Selective effects of naltrexone on food pleasantness and intake.
        Physiol Behav. 1996; 60: 439-446
        • Roach M.
        More reasons to love chocolate.
        New Women. February. 1989; : 135-236
        • Jaffe J.H.
        Drug addiction and drug abuse.
        in: Spiller G.A. The Methylxanthine Beverages and Foods Chemistry, Consumption and Health Effects. Alan R. Liss, New York, NY1984: 149-178
        • Waterhouse A.L.
        • Shirley J.R.
        • Donovan J.L.
        Antioxidants in chocolate.
        Lancet. 1996; 348: 834
      1. The authors thank Gary Wenk and Iris Bell, who provided valuable consultation throughout the development of this review study, and Cyndi Thompson, PhD, RD, for reviewing and commenting on the manuscript.